https://pharminent.com/week-in-review/week-in-review-intelligence-brief-may-23-2026/ 2026-05-23T22:58:56Z Pharminent en Week in Review • INTELLIGENCE BRIEF • May 23, 2026 2026-05-23T22:58:53Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-may-22-2026/ 2026-05-23T01:02:30Z Pharminent en Oncology Intelligence Digest • May 22, 2026 2026-05-23T01:02:27Z Blog https://pharminent.com/81009-2/ 2026-05-23T00:54:18Z Pharminent en 2026-05-23T00:54:12Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-may-22-2026/ 2026-05-22T19:57:31Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • May 22, 2026 2026-05-22T19:57:29Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-may-22-2026/ 2026-05-22T19:52:35Z Pharminent en GLP-1 Competitive Market Digest • Weekly • May 22, 2026 2026-05-22T19:52:33Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-22-2026/ 2026-05-22T17:30:34Z Pharminent en Strategic News Watch • May 22, 2026 2026-05-22T17:30:32Z Blog https://pharminent.com/parkinsons-drug-from-biogen-denali-comes-up-short/ 2026-05-22T16:17:05Z Pharminent en Parkinson's drug from Biogen, Denali comes up short 2026-05-22T14:46:00Z Blog https://pharminent.com/kelun-merck-validate-trop2-keytruda-pairing-in-lung-cancer-with-improved-survival/ 2026-05-22T16:17:07Z Pharminent en Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival 2026-05-22T14:04:07Z Blog https://pharminent.com/gilead-inks-140m-api-supply-deal-tightening-ties-to-korean-manufacturer/ 2026-05-22T16:17:08Z Pharminent en Gilead inks $140M API supply deal, tightening ties to Korean manufacturer 2026-05-22T12:09:36Z Blog https://pharminent.com/gbl-joins-cvc-in-10-7bn-takeover-bid-for-recordati/ 2026-05-22T16:17:09Z Pharminent en GBL joins CVC in 10.7bn takeover bid for Recordati 2026-05-22T10:37:57Z Blog https://pharminent.com/gilead-sciences-completes-tubulis-acquisition-for-5bn/ 2026-05-22T16:17:09Z Pharminent en Gilead Sciences completes Tubulis acquisition for $5bn 2026-05-22T10:19:52Z Blog